Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine for Prevention of Contrast-Induced Nephropathy in Coronary Angiography Patients
IRCT20180921041079N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in contrast-induced nephropathy (CIN), sponsored by Guilan University of Medical Sciences. Started Nov 2018; status: completed.
02
Drugs
levocarnitine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT20180921041079N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180921041079N1.